ACM
IDXX icon

Azimuth Capital Management’s Idexx Laboratories IDXX Stock Holding History

Azimuth Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$18.5M Buy
33,769
+17,265
+105% +$9.08M 0.79% 33
2021
Q4 		$10.9M Buy
16,504
+301
+2% +$189K 0.44% 87
2021
Q3 		$10.1M Sell
16,203
-15,166
-48% -$10.2M 0.43% 90
2021
Q2 		$19.8M Sell
31,369
-4,056
-11% -$2.24M 0.86% 27
2021
Q1 		$17.3M Sell
35,425
-726
-2% -$364K 0.82% 30
2020
Q4 		$18.1M Sell
36,151
-655
-2% -$293K 0.9% 30
2020
Q3 		$14.5M Buy
36,806
+18
+0% +$6.66K 0.85% 30
2020
Q2 		$12.1M Sell
36,788
-242
-0.7% -$70.1K 0.77% 42
2020
Q1 		$8.97M Buy
37,030
+1,355
+4% +$354K 0.67% 52
2019
Q4 		$9.32M Buy
35,675
+118
+0.3% +$31.1K 0.57% 70
2019
Q3 		$9.67M Sell
35,557
-9,296
-21% -$2.59M 0.63% 58
2019
Q2 		$12.3M Sell
44,853
-1,017
-2% -$251K 0.82% 34
2019
Q1 		$10.3M Buy
+45,870
New +$9.47M 0.69% 45

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Azimuth Capital Management's IDXX Position: Q1 2022 in Review

Azimuth Capital Management increased its Idexx Laboratories (IDXX) stake by 105% in Q1 2022, buying an estimated $9.08M and bringing the position to 33,769 shares worth $18.5M. The position accounts for 0.79% of the portfolio, ranked #33.

Azimuth Capital Management first reported a position in IDXX in Q1 2019 and has held it in 13 quarters since. The position peaked at $19.8M in Q2 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • Azimuth Capital Management held 33,769 shares of Idexx Laboratories worth $18.5M as of Q1 2022.
  • Azimuth Capital Management bought 17,265 Idexx Laboratories shares in Q1 2022, an estimated $9.08M.
  • Idexx Laboratories made up 0.79% of Azimuth Capital Management's portfolio in Q1 2022, its #33 holding.
  • Azimuth Capital Management first reported a position in Idexx Laboratories in Q1 2019 and has held it in 13 quarters since.
  • Azimuth Capital Management's Idexx Laboratories position peaked at $19.8M in Q2 2021.
  • 1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.